Celanese [CE] vs Asp Isotopes [ASPI] Detailed Stock Comparison
Celanese
NYSE
Loading...
Asp Isotopes
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Celanese wins in 10 metrics, Asp Isotopes wins in 8 metrics, with 0 ties. Celanese appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Celanese | Asp Isotopes | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 6.78 | -14.17 | Asp Isotopes |
| Price-to-Book Ratio | 1.02 | 15.14 | Celanese |
| Debt-to-Equity Ratio | 234.12 | 84.08 | Asp Isotopes |
| PEG Ratio | 5.05 | -59.53 | Asp Isotopes |
| EV/EBITDA | 10.25 | -23.83 | Asp Isotopes |
| Profit Margin (TTM) | -16.54% | 38.60% | Asp Isotopes |
| Operating Margin (TTM) | 7.41% | -721.89% | Celanese |
| EBITDA Margin (TTM) | 7.41% | N/A | N/A |
| Return on Equity | -24.98% | -115.46% | Celanese |
| Return on Assets (TTM) | 2.66% | -26.14% | Celanese |
| Free Cash Flow (TTM) | $531.00M | $-28.07M | Celanese |
| Dividend Yield | 2.63% | N/A | N/A |
| 1-Year Return | -63.09% | 313.43% | Asp Isotopes |
| Price-to-Sales Ratio (TTM) | 0.53 | 185.28 | Celanese |
| Enterprise Value | $17.94B | $666.51M | Celanese |
| EV/Revenue Ratio | 1.78 | 151.29 | Celanese |
| Gross Profit Margin (TTM) | 19.92% | 29.67% | Asp Isotopes |
| Revenue per Share (TTM) | $92 | $0 | Celanese |
| Earnings per Share (Diluted) | $-15.12 | $-0.59 | Asp Isotopes |
| Beta (Stock Volatility) | 1.14 | 3.38 | Celanese |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Celanese vs Asp Isotopes Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Celanese | -7.05% | -17.29% | -16.48% | 6.94% | -29.40% | -29.04% |
| Asp Isotopes | -1.54% | -14.71% | 27.57% | 65.37% | 55.30% | 80.77% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Celanese | -63.09% | -56.20% | -51.92% | -25.27% | 66.90% | 163.29% |
| Asp Isotopes | 313.43% | 218.93% | 218.93% | 218.93% | 218.93% | 218.93% |
Performance & Financial Health Analysis: Celanese vs Asp Isotopes
| Metric | CE | ASPI |
|---|---|---|
| Market Information | ||
| Market Cap | $5.31B | $816.25M |
| Market Cap Category | Mid cap | Small cap |
| 10 Day Avg. Volume | 1,830,360 | 4,793,356 |
| 90 Day Avg. Volume | 1,712,727 | 4,457,119 |
| Last Close | $48.55 | $8.93 |
| 52 Week Range | $36.29 - $144.59 | $1.86 - $10.82 |
| % from 52W High | -66.42% | -17.47% |
| All-Time High | $176.50 (Jan 03, 2022) | $10.82 (Jul 25, 2025) |
| % from All-Time High | -72.49% | -17.47% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.09% | 0.31% |
| Quarterly Earnings Growth | -0.09% | 0.31% |
| Financial Health | ||
| Profit Margin (TTM) | -0.17% | 0.39% |
| Operating Margin (TTM) | 0.07% | -7.22% |
| Return on Equity (TTM) | -0.25% | -1.15% |
| Debt to Equity (MRQ) | 234.12 | 84.08 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $47.40 | $0.59 |
| Cash per Share (MRQ) | $8.69 | $0.75 |
| Operating Cash Flow (TTM) | $902.00M | $-16,894,872 |
| Levered Free Cash Flow (TTM) | $520.50M | $-20,013,620 |
| Dividends | ||
| Last 12-Month Dividend Yield | 2.63% | N/A |
| Last 12-Month Dividend | $1.43 | N/A |
Valuation & Enterprise Metrics Analysis: Celanese vs Asp Isotopes
| Metric | CE | ASPI |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 6.78 | -14.17 |
| Forward P/E | 5.05 | -59.53 |
| PEG Ratio | 5.05 | -59.53 |
| Price to Sales (TTM) | 0.53 | 185.28 |
| Price to Book (MRQ) | 1.02 | 15.14 |
| Market Capitalization | ||
| Market Capitalization | $5.31B | $816.25M |
| Enterprise Value | $17.94B | $666.51M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.78 | 151.29 |
| Enterprise to EBITDA | 10.25 | -23.83 |
| Risk & Other Metrics | ||
| Beta | 1.14 | 3.38 |
| Book Value per Share (MRQ) | $47.40 | $0.59 |
Financial Statements Comparison: Celanese vs Asp Isotopes
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CE | ASPI |
|---|---|---|
| Revenue/Sales | $2.39B | $1.10M |
| Cost of Goods Sold | $1.91B | $774,765 |
| Gross Profit | $476.00M | $326,840 |
| Research & Development | $31.00M | $1.53M |
| Operating Income (EBIT) | $175.00M | $-7.95M |
| EBITDA | $364.00M | $-8.23M |
| Pre-Tax Income | $-3.00M | $-8.53M |
| Income Tax | $9.00M | $-70,720 |
| Net Income (Profit) | $-17.00M | $-8.46M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CE | ASPI |
|---|---|---|
| Cash & Equivalents | $951.00M | $55.97M |
| Total Current Assets | $5.42B | $59.03M |
| Total Current Liabilities | $2.80B | $8.18M |
| Long-Term Debt | $12.66B | $36.96M |
| Total Shareholders Equity | $5.62B | $45.73M |
| Retained Earnings | $11.08B | $-64.62M |
| Property, Plant & Equipment | $10.39B | $1.02M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CE | ASPI |
|---|---|---|
| Operating Cash Flow | $26.00M | $-7.16M |
| Capital Expenditures | N/A | $-2.36M |
| Free Cash Flow | $-65.00M | $-5.53M |
| Debt Repayment | $-3.16B | $-262,304 |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | CE | ASPI |
|---|---|---|
| Shares Short | 6.40M | 16.34M |
| Short Ratio | 3.92 | 4.67 |
| Short % of Float | 0.08% | 0.24% |
| Average Daily Volume (10 Day) | 1,830,360 | 4,793,356 |
| Average Daily Volume (90 Day) | 1,712,727 | 4,457,119 |
| Shares Outstanding | 109.33M | 72.07M |
| Float Shares | 108.80M | 54.53M |
| % Held by Insiders | 0.00% | 0.23% |
| % Held by Institutions | 1.03% | 0.37% |
Dividend Analysis & Yield Comparison: Celanese vs Asp Isotopes
| Metric | CE | ASPI |
|---|---|---|
| Last 12-Month Dividend | $1.43 | N/A |
| Last 12-Month Dividend Yield | 2.63% | N/A |
| 3-Year Avg Annual Dividend | $2.34 | N/A |
| 3-Year Avg Dividend Yield | 0.53% | N/A |
| 3-Year Total Dividends | $7.01 | N/A |
| Ex-Dividend Date | Feb 25, 2025 | N/A |